RCMI Coordinating Center (RCMI CC) Header Logo

Connection

KiTani Parker-Lemieux to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications KiTani Parker-Lemieux has written about Xenograft Model Antitumor Assays.
KiTani Parker-Lemieux
Connection Strength
0.051
Xenograft Model Antitumor Assays
  1. Johnson KP, Yearby LA, Stoute D, Burow ME, Rhodes LV, Gray M, Carriere P, Tilghman SL, McLachlan JA, Ochieng J. In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models. J Health Care Poor Underserved. 2013 Feb; 24(1 Suppl):104-11.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support